Segawa D, Hatori N, Yoshizu H, Uriuda Y, Shimizu M, Tanaka S
Department of Surgery II, National Defense Medical College, Saitama, Japan.
J Thorac Cardiovasc Surg. 1998 Apr;115(4):925-30. doi: 10.1016/S0022-5223(98)70375-7.
The objective of this study was to investigate the protective effects of nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester hydrochloride, on reperfusion injury of the brain under hypothermic circulatory arrest.
After cardiopulmonary bypass was established using 12 piglets each weighing about 30 kg, the animals were cooled to a brain temperature of 20 degrees C and circulatory arrest was performed for 90 minutes followed by reperfusion for 120 minutes. The level of nitric oxide within the brain was measured with a needle electrode inserted into the brain. In the treatment group, N(G)-nitro-L-arginine methyl ester hydrochloride was administered with an intravenous injection of 1.5 mg/kg at the onset of the reperfusion followed by a 60-minute continuous venous infusion of 1.5 mg/kg/hr.
In the control group, nitric oxide levels within the brain increased not during ischemia but during reperfusion, and the level after 120 minutes of reperfusion increased significantly compared with that of before circulatory arrest. But in the treatment group, N(G)-nitro-L-arginine methyl ester hydrochloride administered at the onset of reperfusion inhibited nitric oxide production during reperfusion. A significant difference was observed between the groups regarding the nitric oxide level after 120 minutes of reperfusion. Regarding cerebral blood flow, excess lactate, and cerebral tissue water content, no significant difference was observed between the groups. However, recovery of somatosensory evoked potential after 120 minutes of reperfusion was detected in all six animals in the treatment group, but none in the control group (p = 0.001).
These data suggest that N(G)-nitro-L-arginine methyl ester hydrochloride protects the brain against reperfusion injury under hypothermic circulatory arrest.
本研究的目的是探讨一氧化氮合酶抑制剂盐酸N(G)-硝基-L-精氨酸甲酯对低温循环停止下脑再灌注损伤的保护作用。
使用12只体重约30kg的仔猪建立体外循环后,将动物冷却至脑温20℃,进行90分钟的循环停止,随后再灌注120分钟。用插入脑内的针电极测量脑内一氧化氮水平。在治疗组中,在再灌注开始时静脉注射1.5mg/kg盐酸N(G)-硝基-L-精氨酸甲酯,随后以1.5mg/kg/小时的速度持续静脉输注60分钟。
在对照组中,脑内一氧化氮水平在缺血期间未升高,而是在再灌注期间升高,再灌注120分钟后的水平与循环停止前相比显著升高。但在治疗组中,再灌注开始时给予的盐酸N(G)-硝基-L-精氨酸甲酯抑制了再灌注期间一氧化氮的产生。再灌注120分钟后两组间一氧化氮水平存在显著差异。关于脑血流量、过量乳酸和脑组织含水量,两组间未观察到显著差异。然而,治疗组的所有6只动物在再灌注120分钟后检测到体感诱发电位恢复,而对照组无一恢复(p = 0.001)。
这些数据表明,盐酸N(G)-硝基-L-精氨酸甲酯可保护脑免受低温循环停止下的再灌注损伤。